Introduction: Dipyrone has been positioned in several countries
as one of the first over-the-counter options for pain management.
Its possible adverse effects are known worldwide; among them,
agranulocytosis is the most lethal, with a
Dipyrone-related granulocytopenia. Case report
Audifarma |
| Tiempo de lectura: Min
- Tema: Farmacovigilancia
- Autores: Jorge Enrique Machado-Alba, Leidy Viviana Sánchez-Morales, Luisa Fernanda Rodríguez-Ramírez
- Idiomas: Inglés
- Palabras clave: "Dipirona, Agra- nulocitosis, Farmacovigilancia, Efectos Adversos, Reporte de casoDipyrone, Agranulo- cytosis, Pharmacovigilance, Ad- verse effects, Case Report"
Machado-Alba JE, Sánchez-Morales LV, Rodriguez-Ramirez LF. Dipyrone-related granulocytopenia. Case report. Colombian Journal of Anesthesiology. 2018;46:327-330. Enlace: http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0120-33472018000400327&lng=en&nrm=iso